Biochemistry
ARTICLE
(12) Gay, S. C., Shah, M. B., Talakad, J. C., Maekawa, K., Roberts,
A. G., Wilderman, P. R., Sun, L., Yang, J. Y., Huelga, S. C., Hong, W. X.,
Zhang, Q., Stout, C. D., and Halpert, J. R. (2010) Crystal structure of a
cytochrome P450 2B6 genetic variant in complex with the inhibitor 4-(4-
chlorophenyl)imidazole at 2.0-Å resolution. Mol. Pharmacol. 77, 529–538.
(13) Agundez, J. A., Martinez, C., and Benitez, J. (1995) Metabolism
of aminopyrine and derivatives in man: In vivo study of monomorphic
and polymorphic metabolic pathways. Xenobiotica 25, 417–427.
(14) Geisslinger, G., Bocker, R., and Levy, M. (1996) High-perfor-
mance liquid chromatographic analysis of dipyrone metabolites to study
their formation in human liver microsomes. Pharm. Res. 13, 1272–1275.
(15) Vlahov, V., Badian, M., Verho, M., and Bacracheva, N. (1990)
Pharmacokinetics of metamizol metabolites in healthy subjects after a
single oral dose of metamizol sodium. Eur. J. Clin. Pharmacol.
38, 61–65.
(16) Levy, M., Zylber-Katz, E., and Rosenkranz, B. (1995) Clinical
pharmacokinetics of dipyrone and its metabolites. Clin. Pharmacokinet.
28, 216–234.
(17) Kanaeva, I. P., Nikityuk, O. V., Davydov, D. R., Dedinskii, I. R.,
Koen, Y. M., Kuznetsova, G. P., Skotselyas, E. D., Bachmanova, G. I., and
Archakov, A. I. (1992) Comparative study of monomeric reconstituted
and membrane microsomal monooxygenase systems of the rabbit liver.
II. Kinetic parameters of reductase and monooxygenase reactions. Arch.
Biochem. Biophys. 298, 403–412.
(18) Gram, T. E., Wilson, J. T., and Fouts, J. R. (1968) Some
characteristics of hepatic microsomal systems which metabolize amino-
pyrine in the rat and rabbit. J. Pharmacol. Exp. Ther. 159, 172–181.
(19) Bast, A., and Noordhoek, J. (1980) Inhibition of aminopyrine
demethylation and binding to cytochrome P-450 by its main metabolites
in rat liver microsomes. Br. J. Pharmacol. 68, 121P–122P.
(20) Noda, A., Tsubone, N., Mihara, M., Goromaru, T., and Iguchi,
S. (1976) Formation of 4-formylaminoantipyrine as a new metabolite of
aminopyrine. II. Enzymatic demethylation and oxidation of aminopyrine
and 4-monomethylaminoantipyrine. Chem. Pharm. Bull. 24, 3229–3231.
(21) Agundez, J. A., Carrillo, J. A., Martinez, C., and Benitez, J.
(1995) Aminopyrine metabolism in man: The acetylation of aminoan-
tipyrine cosegregates with acetylation of caffeine. Ther. Drug Monit.
17, 1–5.
(22) Muralidhara, B. K., Sun, L., Negi, S., and Halpert, J. R. (2008)
Thermodynamic fidelity of the mammalian cytochrome P450 2B4 active
site in binding substrates and inhibitors. J. Mol. Biol. 377, 232–245.
(23) Gay, S. C., Sun, L., Maekawa, K., Halpert, J. R., and Stout, C. D.
(2009) Crystal structures of cytochrome P450 2B4 in complex with the
inhibitor 1-biphenyl-4-methyl-1H-imidazole: Ligand-induced structural
response through R-helical repositioning. Biochemistry 48, 4762–4771.
(24) Scott, E. E., Spatzenegger, M., and Halpert, J. R. (2001) A
truncation of 2B subfamily cytochromes P450 yields increased expres-
sion levels, increased solubility, and decreased aggregation while retain-
ing function. Arch. Biochem. Biophys. 395, 57–68.
(30) Renaud, J. P., Davydov, D. R., Heirwegh, K. P., Mansuy, D., and
Hui Bon Hoa, G. H. (1996) Thermodynamic studies of substrate
binding and spin transitions in human cytochrome P-450 3A4 expressed
in yeast microsomes. Biochem. J. 319 (Part 3), 675–681.
(31) Regal, K. A., and Nelson, S. D. (2000) Orientation of caffeine
within the active site of human cytochrome P450 1A2 based on NMR
longitudinal (T1) relaxation measurements. Arch. Biochem. Biophys.
384, 47–58.
(32) Hummel, M. A., Gannett, P. M., Aguilar, J. S., and Tracy, T. S.
(2004) Effector-mediated alteration of substrate orientation in cyto-
chrome P450 2C9. Biochemistry 43, 7207–7214.
(33) Piotto, M., Saudek, V., and Sklenar, V. (1992) Gradient-tailored
excitation for single-quantum NMR spectroscopy of aqueous solutions.
J. Biomol. NMR 2, 661–665.
(34) Kowalewski, J., and M€aler, L. (2006) Nuclear spin relaxation in
liquids: Theory, experiments, and applications, Taylor & Francis, New
York.
(35) Mayer, M., and Meyer, B. (2001) Group epitope mapping by
saturation transfer difference NMR to identify segments of a ligand in
direct contact with a protein receptor. J. Am. Chem. Soc. 123, 6108–6117.
(36) Meyer, B., and Peters, T. (2003) NMR spectroscopy techni-
ques for screening and identifying ligand binding to protein receptors.
Angew. Chem. 42, 864–890.
(37) Parella, T., Adell, P., Sꢀanchez-Ferrando, F., and Virgili, A.
(1998) Effective multiple-solvent suppression scheme using the excita-
tion sculpting principle. Magn. Reson. Chem. 36, 245–249.
(38) Aires-de-Sousa, J., Hemmer, M. C., and Gasteiger, J. (2002)
1
Prediction of H NMR chemical shifts using neural networks. Anal.
Chem. 74, 80–90.
(39) Bruce, S. D., Higinbotham, J., Marshall, I., and Beswick, P. H.
(2000) An analytical derivation of a popular approximation of the Voigt
function for quantification of NMR spectra. J. Magn. Reson. 142, 57–63.
(40) Kielkopf, J. F. (1973) New approximation to the Voigt function
with applications to spectral-line profile analysis. J. Opt. Soc. Am.
63, 987–995.
(41) Marshall, I., Bruce, S. D., Higinbotham, J., MacLullich, A.,
Wardlaw, J. M., Ferguson, K. J., and Seckl, J. (2000) Choice of spectro-
scopic lineshape model affects metabolite peak areas and area ratios.
Magn. Reson. Med. 44, 646–649.
(42) Marshall, I., Higinbotham, J., Bruce, S., and Freise, A. (1997)
1
Use of Voigt lineshape for quantification of in vivo H spectra. Magn.
Reson. Med. 37, 651–657.
(43) Stoica, P., Selen, Y., Sandgren, N., and Van Huffel, S. (2004)
Using prior knowledge in SVD-based parameter estimation for magnetic
resonance spectroscopy: The ATP example. IEEE Trans. Biomed. Eng.
51, 1568–1578.
(44) Chen, H., Van Huffel, S., van Ormondt, D., and de Beer, R.
(1996) Parameter estimation with prior knowledge of known signal
poles for the quantification of NMR spectroscopy data in the time
domain. J. Magn. Reson., Ser. A 119, 225–234.
(45) Viereck, N., Nørgaard, L., Bro, R., and Engelsen, S. B. (2006)
Chemometric Analysis of NMR Data. In Modern Magnetic Resonance (Webb,
G. A., Ed.) pp 1833-1843, Springer, Dordrecht, The Netherlands.
(46) Gay, S. C., Roberts, A. G., Maekawa, K., Talakad, J. C., Hong,
W. X., Zhang, Q., Stout, C. D., and Halpert, J. R. (2010) Structures of
cytochrome P450 2B4 complexed with the antiplatelet drugs ticlopidine
and clopidogrel. Biochemistry 49, 8709–8720.
(47) Villafranca, J. J. (1989) Paramagnetic probes of macromole-
cules. Methods Enzymol. 177, 403–413.
(48) Solomon, I. (1955) Relaxation processes in a system of two
spins. Phys. Rev. 99, 559–565.
(49) Modi, S., Primrose, W. U., Boyle, J. M., Gibson, C. F., Lian, L. Y.,
and Roberts, G. C. (1995) NMR studies of substrate binding to
cytochrome P450 BM3: Comparisons to cytochrome P450cam. Bio-
chemistry 34, 8982–8988.
(50) Dwek, R. A. (1973) Nuclear Magnetic Resonance (N.M.R.) in
Biochemistry: Applications to Enzyme Systems, Oxford University Press,
New York.
(25) Scott, E. E., He, Y. A., Wester, M. R., White, M. A., Chin, C. C.,
Halpert, J. R., Johnson, E. F., and Stout, C. D. (2003) An open
conformation of mammalian cytochrome P450 2B4 at 1.6-Å resolution.
Proc. Natl. Acad. Sci. U.S.A. 100, 13196–13201.
(26) Omura, T., and Sato, R. (1964) The carbon monoxide-binding
pigment of liver microsomes. II. Solubilization, purification, and proper-
ties. J. Biol. Chem. 239, 2379–2385.
(27) Fernando, H., Halpert, J. R., and Davydov, D. R. (2006)
Resolution of multiple substrate binding sites in cytochrome P450
3A4: The stoichiometry of the enzyme-substrate complexes probed by
FRET and Job’s titration. Biochemistry 45, 4199–4209.
(28) Morrison, J. F. (1969) Kinetics of the reversible inhibition of
enzyme-catalysed reactions by tight-binding inhibitors. Biochim. Biophys.
Acta 185, 269–286.
(29) Davydov, D. R., Deprez, E., Hoa, G. H., Knyushko, T. V.,
Kuznetsova, G. P., Koen, Y. M., and Archakov, A. I. (1995) High-
pressure-induced transitions in microsomal cytochrome P450 2B4 in
solution: Evidence for conformational inhomogeneity in the oligomers.
Arch. Biochem. Biophys. 320, 330–344.
2133
dx.doi.org/10.1021/bi101797v |Biochemistry 2011, 50, 2123–2134